Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Sevuparin sodium by Modus Therapeutics for Endotoxemia: Likelihood of Approval
Sevuparin sodium is under clinical development by Modus Therapeutics and currently in Phase I for Endotoxemia. According to GlobalData, Phase...